Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases

125,551disease mentions

18,081distinct diseases extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted diseases

Showing 11,041–11,100 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Poststroke depression1 Poststroke depression (PSD)1 Poststroke dysphagia1 Poststroke motor dysfunction1 Postural orthostatic tachycardia syndrome (POTS)1 Potocki-Lupski syndrome1 Prader–Willi syndrome1 Pre-eclampsia12651 Pre-eclampsia3741 Pre-eclampsia4941 Precursor T-Lymphoblastic Lymphoma1 Prediabetes5381 PreeclampsiaPreeclampsia1 Preganglionic trigeminal nerve palsy (PrGTP)1 Pregnancy-related anaemia1 Pregnant women1 Premature acute coronary syndrome1 Premature coronary artery disease1 Premature ventricular complexes (PVCs)1 Preoperative anxiety1 Preprocedural ASILs1 Preterm birth (PTB)1 Primary adrenal leiomyosarcoma1 Primary and secondary cancers of the liver1 Primary bile duct lymphoma1 Primary bladder perivascular epithelioid cell tumours1 Primary central nervous system T-cell lymphoma1 Primary central nervous system lymphoma (PCNSL)1 Primary cervical lymphoma1 Primary cutaneous aspergillosis1 Primary cutaneous peripheral T-cell lymphoma1 Primary dysmenorrhoea1 Primary graft failure (PGF)1 Primary immunodeficiencies1 Primary intestinal lymphangiectasia1 Primary lung tumours1 Primary lymphoma of the bone1 Primary mucocutaneous tuberculosis1 Primary non-Hodgkin’s lymphoma1 Primary ovarian lymphoma1 Primary palmar hyperhidrosis (PPH)1 Primary postpartum haemorrhage1 Primary progressive aphasia (PPA)1 Primary pulmonary lymphoma1 Primary spinal angiosarcoma1 Primary tracheal carcinoid1 Primary urethral adenocarcinoma1 Primary uterine rupture1 Primary vulvar adenocarcinomas1 Progressive Familial lntrahepatic Cholestasis (PFIC)1 Progressive Fibrosing ILD1 Progressive Fibrosis Interstitial Lung Diseases (PFILD)1 Progressive Neurodegenerative Diseases1 Progressive SystemicSclerosis1 Progressive disease331 Progressive in-stent restenosis1 Progressive interstitial lung disease (ILD)1 Proximal basilar artery aneurysms1 Proximal tibial stress fractures (PTSFs)1 Pruritic urticarial papules and plaques of pregnancy1

View all 18,081 diseases on one page

Articles mentioning diseases

23,712 articles · page 220 of 1976

300 Therapeutic potential of allogeneic CAR-expressing iNKT cells in preclinical models for tumors and autoimmune diseases

jitc · abstract · 2025-11-04 · 10 matching annotations

96.6%

cancer ALL autoimmune diseases CLL SLE GvHD graft-versus-host disease NSG mice GPC3 Medicilon’s Ethics Board

…fective allogeneic platform for CAR-based immunotherapy in both cancer and autoimmune diseases, providing a strong foundation for furt…

532 A phase 1 dose escalation and dose expansion trial of NP-101 in patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 10 matching annotations

88.4%

COVID-19 advanced/metastatic cancer advanced/metastatic solid tumors hepatocellular carcinoma type 2 diabetes mellitus ECOG Performance Status NP-101

….0002). A double-blind, randomized, placebo-controlled trial in COVID-19 patients14 demonstrated that NP-101 led to a faster decline in …

548 A Phase 1/2 study of a first-in-class non-cellular antibody-drug conjugate, micvotabart pelidotin (micvo), in combination with pembrolizumab in advanced head & neck squamous cell carcinoma (HNSCC)

jitc · abstract · 2025-11-04 · 10 matching annotations

98.2%

HNSCC Pembrolizumab micvo

…y pretreated patients across multiple tumor types, particularly HNSCC, with a manageable safety profile. Therefore, exploring the com…

642 Synergistic anti-leukemic effect of NKTR-255 and TGFβ-imprinted CD33.CAR natural killer cells

jitc · abstract · 2025-11-04 · 10 matching annotations

94.6%

Acute myeloid leukemia neuroblastoma AML NKTR-255

…Background Acute myeloid leukemia (AML) accounts for 25% of acute leukemias in children and 33% i…

722 Dual perspectives, elevated impact: effect of short-format education with a multispecialty panel on treatment of advanced basal cell carcinoma (aBCC)

jitc · abstract · 2025-11-04 · 10 matching annotations

98.0%

BCC aBCC locally advanced or metastatic disease cemiplimab

…nowledge and competence (K/C) related to choosing patients with BCC who should receive systemic therapies, including IOs. We used a…

726 From cancer to cardiovascular disease: a SEER based competing-risk analysis of cause-specific mortality in stage IV melanoma before and after ICI adoption

jitc · abstract · 2025-11-04 · 10 matching annotations

91.4%

metastatic melanoma CVD myocarditis ipilimumab Pembrolizumab SEER 18 surgical treatment American Heart Association N Engl J Med J Am Coll Cardiol

…ne checkpoint inhibitors (ICIs) have revolutionized therapy for metastatic melanoma, substantially improving survival outcomes. 1 2 However, as ICI…

737 IL-33 drives KRAS G12D-specific expansion of regulatory T cells in colorectal cancer

jitc · abstract · 2025-11-04 · 10 matching annotations

98.2%

colorectal cancer CRC Severance Hospital

… FOXP3+CD25+CD127– Treg cells in colorectal cancer.KRAS-mutated colorectal cancer (CRC) tumors exhibited significantly higher frequencies of both…

786 STING pathway activation enhances anti-tumor immune responses and therapeutic efficacy of DNA damage repair inhibition

jitc · abstract · 2025-11-04 · 10 matching annotations

92.5%

Small cell lung cancer SCLC ataxia telangiectasia topotecan M6620 chemotherapy VX970

…Background Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Recent cl…

832 Integrative multi-omics analysis reveals enrichment of exhausted CD8+ and CD4+CD8+ T cells in the renal cell carcinoma tumor microenvironment

jitc · abstract · 2025-11-04 · 10 matching annotations

96.3%

head and neck squamous cell carcinoma Renal cell carcinoma non-small cell lung cancer RCC immunotherapy Providence St. Joseph Health Institutional Review Board – Oregon immunotherapy-refractory

…cell-cell interactions among a cohort of primary breast cancer, head and neck squamous cell carcinoma, non-small cell lung cancer, and RCC specimens. Putative tumor …

895 The lack of abscopal effects with oncolytic virus immunotherapy is due to a dominant anti-viral – rather than anti-cancer – T cell response

jitc · abstract · 2025-11-04 · 10 matching annotations

99.7%

melanoma Talimogene laherparepvec talimogene laherparapvec pembrolizumab Massachusetts General Hospital MGH MGH Pathology Flow Core

…, Cohen S. Genetic factors associated with clinical response in melanoma patients treated with talimogene laherparapvec: a single-instit…

902 CD63 as a marker of T cell dysfunction and immune evasion in irradiated glioblastoma

jitc · abstract · 2025-11-04 · 10 matching annotations

99.6%

glioblastoma TIMP-1 IACUC #2019-0042

… may serve as a novel immunoregulatory marker in the irradiated glioblastoma tumor microenvironment. Ongoing studies will determine whether …

974 Bi-functional TLR9-targeted and DNMT1-specific RNA aptamer for immunotherapy of acute myeloid leukemia

jitc · abstract · 2025-11-04 · 10 matching annotations

97.4%

acute myeloid leukemia AML azacitidine venetoclax

…decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. 2016. PMID: 26796361; PMCID: PMC4817311.Esposito CL, Au…